A detailed history of Sg Americas Securities, LLC transactions in Geron Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 22,630 shares of GERN stock, worth $71,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,630
Previous 17,071 32.56%
Holding current value
$71,737
Previous $72,000 43.06%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$4.17 - $4.99 $23,181 - $27,739
5,559 Added 32.56%
22,630 $103,000
Q2 2024

Jul 12, 2024

SELL
$3.1 - $5.09 $112,768 - $185,158
-36,377 Reduced 68.06%
17,071 $72,000
Q1 2024

May 06, 2024

SELL
$1.75 - $3.44 $243,244 - $478,149
-138,997 Reduced 72.23%
53,448 $176,000
Q4 2023

Jan 12, 2024

BUY
$1.74 - $2.31 $301,663 - $400,484
173,370 Added 908.89%
192,445 $406,000
Q3 2023

Oct 13, 2023

BUY
$2.11 - $3.28 $40,248 - $62,565
19,075 New
19,075 $40,000
Q1 2023

Apr 28, 2023

BUY
$2.14 - $3.4 $263,297 - $418,322
123,036 Added 195.69%
185,910 $403,000
Q4 2022

Feb 02, 2023

SELL
$2.03 - $2.42 $128,762 - $153,500
-63,430 Reduced 50.22%
62,874 $152,000
Q3 2022

Oct 31, 2022

BUY
$1.67 - $2.94 $15,713 - $27,662
9,409 Added 8.05%
126,304 $296,000
Q2 2022

Jul 29, 2022

BUY
$1.19 - $1.65 $87,094 - $120,761
73,189 Added 167.46%
116,895 $181,000
Q1 2022

Apr 29, 2022

SELL
$0.99 - $1.6 $54,780 - $88,534
-55,334 Reduced 55.87%
43,706 $59,000
Q4 2021

Feb 07, 2022

SELL
$1.22 - $1.72 $132,162 - $186,327
-108,330 Reduced 52.24%
99,040 $121,000
Q3 2021

Nov 01, 2021

BUY
$1.2 - $1.5 $225,934 - $282,418
188,279 Added 986.22%
207,370 $284,000
Q2 2021

Aug 12, 2021

SELL
$1.25 - $1.83 $31,682 - $46,383
-25,346 Reduced 57.04%
19,091 $27,000
Q1 2021

May 13, 2021

BUY
$1.52 - $2.1 $67,544 - $93,317
44,437 New
44,437 $70,000
Q4 2020

Feb 04, 2021

SELL
$1.55 - $2.05 $1.56 Million - $2.06 Million
-1,006,319 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$1.59 - $2.19 $1.44 Million - $1.98 Million
905,690 Added 900.03%
1,006,319 $1.75 Million
Q2 2020

Jul 20, 2020

BUY
$1.05 - $2.18 $30,978 - $64,316
29,503 Added 41.48%
100,629 $219,000
Q1 2020

Apr 30, 2020

SELL
$0.89 - $1.49 $66,103 - $110,668
-74,274 Reduced 51.08%
71,126 $85,000
Q4 2019

Jan 28, 2020

SELL
$1.27 - $1.54 $266,166 - $322,753
-209,580 Reduced 59.04%
145,400 $198,000
Q3 2019

Nov 04, 2019

BUY
$1.15 - $1.59 $154,381 - $213,449
134,245 Added 60.82%
354,980 $472,000
Q2 2019

Jul 29, 2019

SELL
$1.37 - $2.02 $291,768 - $430,199
-212,970 Reduced 49.1%
220,735 $311,000
Q1 2019

Apr 29, 2019

BUY
$1.01 - $1.83 $380,998 - $690,323
377,226 Added 667.9%
433,705 $720,000
Q4 2018

Feb 01, 2019

BUY
$0.98 - $1.85 $27,617 - $52,134
28,181 Added 99.59%
56,479 $56,000
Q3 2018

Nov 06, 2018

SELL
$1.76 - $6.38 $52,162 - $189,090
-29,638 Reduced 51.16%
28,298 $50,000
Q2 2018

Aug 07, 2018

BUY
$3.29 - $4.82 $148,457 - $217,497
45,124 Added 352.2%
57,936 $199,000
Q1 2018

May 03, 2018

SELL
$1.81 - $5.98 $57,945 - $191,443
-32,014 Reduced 71.42%
12,812 $54,000
Q4 2017

Jan 24, 2018

BUY
$1.8 - $2.32 $80,686 - $103,996
44,826
44,826 $81,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.2B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.